Skip to main content
. Author manuscript; available in PMC: 2023 Oct 27.
Published in final edited form as: J Med Chem. 2022 Oct 13;65(20):13714–13735. doi: 10.1021/acs.jmedchem.2c00864

Table 2.

Binding Affinities of Selected PBRM1-BD2 Inhibitors Determined by ITC

ITC Kd (μM)a
compd PBRM1-BD2 PBRM1-BD5 SMARCA2B SMARCA4 ASH1L
5 18.4 ± 3.7 179 ± 92 15.9 ± 9.7 ∼142 NB c
7 0.7 ± 0.2 0.35 ± 0.04 8.1 ± 4.4 5.0 ± 0.7 NB
8 6.9 ± 3.1 3.3 ± 0.4 ND b NB NB
11 9.3 ± 1.1 10.1 ± 1.2 18.4 ± 9.9 69 ± 34 NB
15 5.5 ± 1.0 11.1 ± 1.2 NB NB ND
16 1.5 ± 0.9 3.9 ± 2.6 NB NB ND
34 4.4 ± 1.3 25 ± 17 NB NB ND
a

Kd values for each compound were obtained from ITC measurements and calculated by fitting the data points to a sigmoidal curve. The errors were calculated by standard deviation or error of the fit.

b

ND indicates that the value was not determined.

c

NB indicates the compound did not bind to the bromodomain, as demonstrated by generated heat below 0.15 μcal per second in the ITC traces.